Literature DB >> 871431

Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria.

D M Becker, J D Viljoen, J Katz, S Kramer.   

Abstract

Erythroid ferrochelatase activity has been studied in the normoblasts of patients with porphyria variegata and protoporphyria. Two methods were used for the investigation: one using intact cells and the other lysed cells, each measuring the amount of haem synthesized by normoblasts. In patients with porphyria variegata, ferrochelatase activity estimated by both methods was approximately 50% of the normal, and in protoporphyria the ferrochelatase activity was normal in intact normoblasts but was 20% of the normal in sonicated normoblasts (marrow lysates). It is suggested therefore that in porphyria variegata a dominantly inherited structural gene mutation results in an active ferrochelatase whereas in protoporphyria the genetic mutation results in an unstable ferrochelatase. The mechanism of the enzyme instability is not known though a number of postulates are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871431     DOI: 10.1111/j.1365-2141.1977.tb00637.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Liver metabolomics in a mouse model of erythropoietic protoporphyria.

Authors:  Pengcheng Wang; Madhav Sachar; Grace L Guo; Amina I Shehu; Jie Lu; Xiao-Bo Zhong; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-06-12       Impact factor: 5.858

2.  An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.

Authors:  M Yamada; M Kondo; M Tanaka; R Okeda; S Hatakeyama; T Fukui; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

3.  Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts.

Authors:  J R Bloomer
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

4.  The inherited enzymatic defect in porphyria variegata.

Authors:  J C Deybach; H de Verneuil; Y Nordmann
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.

Authors:  J R Bloomer; K O Morton; R J Reuter; G R Ruth
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

6.  Mouse protoporphyrinogen oxidase. Kinetic parameters and demonstration of inhibition by bilirubin.

Authors:  G C Ferreira; H A Dailey
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

7.  Uptake of protoporphyrin IX by isolated rat liver mitochondria.

Authors:  M E Koller; I Romslo
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

8.  A metabolomic perspective of griseofulvin-induced liver injury in mice.

Authors:  Ke Liu; Jiong Yan; Madhav Sachar; Xinju Zhang; Ming Guan; Wen Xie; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2015-09-05       Impact factor: 5.858

Review 9.  Ferrochelatase and N-alkylated porphyrins.

Authors:  S P Cole; G S Marks
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

10.  Pathogenesis and therapy of liver disease in protoporphyria.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.